Relaxin and its role in the development and treatment of fibrosis

Translational Research

Volumn 154, Issue 1, 2009, Pages 1-6

  Bennett, Robert G ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; RELAXIN; RELAXIN FAMILY PEPTIDE RECEPTOR; UNCLASSIFIED DRUG;

EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; HEART MUSCLE FIBROSIS; HUMAN; KIDNEY FIBROSIS; LIVER FIBROSIS; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SCLERODERMA; SIGNAL TRANSDUCTION;

EID: 66949114470     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.03.007     Document Type: Review

References (55)

1. Sherwood O.D. Relaxin's physiological roles and other diverse actions. Endocr Rev 25 (2004) 205-234
2. Adham I.M., Burkhardt E., Benahmed M., and Engel W. Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem 268 (1993) 26668-26672
3. Bullesbach E.E., and Schwabe C. A novel Leydig cell cDNA-derived protein is a relaxin-like factor. J Biol Chem 270 (1995) 16011-16015
4. Bathgate R.A., Samuel C.S., Burazin T.C., et al. Human relaxin gene 3 (H3) and the equivalent mouse relaxin (M3) gene. Novel members of the relaxin peptide family. J Biol Chem 277 (2002) 1148-1157
5. Hsu S.Y., Nakabayashi K., Nishi S., et al. Activation of orphan receptors by the hormone relaxin. Science 295 (2002) 671-674
6. Bathgate R.A., Ivell R., Sanborn B.M., Sherwood O.D., and Summers R.J. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58 (2006) 7-31
7. Zimmerman S., Steding G., Emmen J.M., et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13 (1999) 681-691
8. McGowan B.M., Stanley S.A., Donovan J., et al. Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Am J Physiol Endocrinol Metab 295 (2008) E278-E286
9. McGowan B.M., Stanley S.A., Smith K.L., et al. Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats. Regul Pept 136 (2006) 72-77
10. Dschietzig T., Bartsch C., Baumann G., and Stangl K. Relaxin-a pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharmacol Ther 112 (2006) 38-56
11. Nistri S., Bigazzi M., and Bani D. Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises. Cardiovasc Hematol Agents Med Chem 5 (2007) 101-108
12. Samuel C.S., and Hewitson T.D. Relaxin in cardiovascular and renal disease. Kidney Int 69 (2006) 1498-1502
13. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.-L., and Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol 170 (2007) 1807-1816
14. Hisaw F.L. The corpus luteum horomone. I. Experimental relaxation of the pelvic ligaments of the guinea pig. Physiol Zool 2 (1929) 59-79
15. Chihal H.J., and Espey L.L. Utilization of the relaxed symphysis pubis of guinea pigs for clues to the mechanism of ovulation. Endocrinology 93 (1973) 1441-1445
16. Sherwood O.D. Relaxin. In: Knobil E., and Neill J.D. (Eds). The physiology of reproduction. 2nd ed (1994), Raven Press, New York 861-1009
17. Zhao L., Samuel C.S., Tregear G.W., Beck F., and Wintour E.M. Collagen studies in late pregnant relaxin null mice. Biol Reprod 63 (2000) 697-703
18. Samuel C.S., Zhao C., Bathgate R.A., et al. The relaxin gene-knockout mouse: a model of progressive fibrosis. Ann N Y Acad Sci 1041 (2005) 173-181
19. Unemori E.N., and Amento E.P. Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts. J Biol Chem 265 (1990) 10681-10685
20. Unemori E.N., Bauer E.A., and Amento E.P. Relaxin alone and in conjunction with interferon-gamma decreases collagen synthesis by cultured human scleroderma fibroblasts. J Invest Dermatol 99 (1992) 337-342
21. Unemori E.N., Beck L.S., Lee W.P., et al. Human relaxin decreases collagen accumulation in vivo in two rodent models of fibrosis. J Invest Dermatol 101 (1993) 280-285
22. Samuel C.S., Zhao C., Yang Q., et al. The relaxin gene knockout mouse: a model of progressive scleroderma. J Invest Dermatol 125 (2005) 692-699
23. Casten G.G., and Boucek R.J. Use of relaxin in the treatment of scleroderma. J Am Med Assoc 166 (1958) 319-324
24. Seibold J.R., Korn J.H., Simms R., et al. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 132 (2000) 871-879
25. Seibold J.R. Relaxins: lessons and limitations. Curr Rheumatol Rep 4 (2002) 275-276
26. Unemori E.N., Pickford L.B., Salles A.L., et al. Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo. J Clin Invest 98 (1996) 2739-2745
27. Samuel C.S., Zhao C., Bathgate R.A., et al. Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J 17 (2003) 121-123
28. Lekgabe E.D., Royce S.G., Hewitson T.D., et al. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology 147 (2006) 5575-5583
29. Mookerjee I., Solly N.R., Royce S.G., Tregear G.W., Samuel C.S., and Tang M.L. Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease. Endocrinology 147 (2006) 754-761
30. Samuel C.S., Royce S.G., Burton M.D., Zhao C., Tregear G.W., and Tang M.L.K. Relaxin plays an important role in the regulation of airway structure and function. Endocrinology 148 (2007) 4259-4266
31. Kamat A.A., Feng S., Bogatcheva N.V., Truong A., Bishop C.E., and Agoulnik A.I. Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 145 (2004) 4712-4720
32. Samuel C.S., Royce S.G., Chen B., et al. RXFP1 protects against airway fibrosis during homeostasis, but not against fibrosis associated with chronic allergic airways disease. Endocrinology (2008) en.2008-1062
33. McDonald G.A., Sarkar P., Rennke H., Unemori E., Kalluri R., and Sukhatme V.P. Relaxin increases ubiquitin-dependent degradation of fibronectin in vitro and ameliorates renal fibrosis in vivo. Am J Physiol Renal Physiol 285 (2003) F59-F67
34. Heeg M.H., Koziolek M.J., Vasko R., et al. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int 68 (2005) 96-109
35. Masterson R., Hewitson T.D., Kelynack K., et al. Relaxin down-regulates renal fibroblast function and promotes matrix remodelling in vitro. Nephrol Dial Transplant 19 (2004) 544-552
36. Mookerjee I., Hewitson T.D., Halls M.L., et al. Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2. FASEB J 23 (2009) 1219-1229
37. Garber S.L., Mirochnik Y., Brecklin C.S., et al. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease. Kidney Int 59 (2001) 876-882
38. Garber S.L., Mirochnik Y., Brecklin C., Slobodskoy L., Arruda J.A., and Dunea G. Effect of relaxin in two models of renal mass reduction. Am J Nephrol 23 (2003) 8-12
39. Lekgabe E.D., Kiriazis H., Zhao C., et al. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats. Hypertension 46 (2005) 412-418
40. Danielson L.A., Welford A., and Harris A. Relaxin improves renal function and histology in aging Munich Wistar Rats. J Am Soc Nephrol 17 (2006) 1325-1333
41. Samuel C.S., Zhao C., Bond C.P., Hewitson T.D., Amento E.P., and Summers R.J. Relaxin-1-deficient mice develop an age-related progression of renal fibrosis. Kidney Int 65 (2004) 2054-2064
42. Hewitson T.D., Mookerjee I., Masterson R., et al. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis. Endocrinology 148 (2007) 660-669
43. Samuel C.S., Unemori E.N., Mookerjee I., et al. Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology 145 (2004) 4125-4133
44. Du X.-J., Samuel C.S., Gao X.-M., Zhao L., Parry L.J., and Tregear G.W. Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57 (2003) 395-404
45. Zhang J., Qi Y.-F., Geng B., et al. Effect of relaxin on myocardial ischemia injury induced by isoproterenol. Peptides 26 (2005) 1632-1639
46. Bathgate R.A.D., Lekgabe E.D., McGuane J.T., et al. Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis. Molec Cell Endocrinol 280 (2008) 30-38
47. Samuel C.S., Hewitson T.D., Zhang Y., and Kelly D.J. Relaxin Ameliorates fibrosis in experimental diabetic cardiomyopathy. Endocrinology 149 (2008) 3286-3293
48. Xu Q., Lekgabe E.D., Gao X.-M., et al. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis. Endocrinology 149 (2008) 476-482
49. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88 (2008) 125-172
50. Bani D., Nistri S., Quattrone S., Bigazzi M., and Bani Sacchi T. The vasorelaxant hormone relaxin induces changes in liver sinusoid microcirculation: a morphologic study in the rat. J Endocrinol 171 (2001) 541-549
51. Williams E.J., Benyon R.C., Trim N., et al. Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo. Gut 49 (2001) 577-583
52. Bennett R.G., Kharbanda K.K., and Tuma D.J. Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem Pharmacol 66 (2003) 867-874
53. Bennett R.G., Dalton S.R., Mahan K.J., Gentry-Nielsen M.J., Hamel F.G., and Tuma D.J. Relaxin receptors in hepatic stellate cells and cirrhotic liver. Biochem Pharmacol 73 (2007) 1033-1040
54. Bennett R.G., Heimann D.G., and Tuma D.J. Relaxin reduces fibrosis in models of progressive and established hepatic fibrosis. Annals NY Acad Sci 1160 (2009) 348-349
55. Feng S., Bogatcheva N.V., Kamat A.A., Truong A., and Agoulnik A.I. Endocrine effects of relaxin overexpression in mice. Endocrinology 147 (2006) 407-414